Introduction
Colitis-associated colorectal cancers are etiologically and molecularly distinct from familial adenomatous polyposis coli-associated colorectal cancer, hereditary non-polyposis coli colorectal cancer and sporadic colorectal cancer. The malignancy occurs in individuals suffering from ulcerative colitis or Crohn's disease (collectively, inflammatory bowel disease) with an incidence that is proportional to the duration of the disease. The neoplastic progression of disease-stricken colonic epithelium is believed to be driven by the chronic inflammatory microenvironment, which promotes the progressive genomic instability of colonic epithelial stem cells by inducing sustained hyperproliferation (regenerative atypia) and by the continuous presence of high local concentrations of DNA-damaging agents, such as reactive oxygen species (reviewed in the studies by Danese and Mantovani (2010) and Saleh and Trinchieri (2011) ).
Although there is considerable debate about the relative importance of the specific factors that contribute to the development of inflammatory bowel disease, there is a consensus that the disease represents an inappropriate immune response to the commensal microbiota in genetically predisposed individuals (reviewed in the studies by Schreiber et al., 2005; Xavier and Podolsky, 2007; Van Limbergen et al., 2009; Kaser et al., 2010; Saleh and Trinchieri, 2011) . In this regard, the contribution of aberrant inflammatory circuits to the development of inflammatory bowel disease has been clearly established by genetic analysis, including genome-wide association studies, which have linked loss-offunction mutations or polymorphisms in genes encoding interleukins, interleukin receptors, chemokine receptors, nucleotide-binding oligomerization domain-like receptors, Toll-like receptor 4, intelectins and prostaglandin receptors to ulcerative colitis, to Crohn's disease or to both. Further support for a principal role of derailed inflammatory circuits is gained from the spontaneous inflammatory bowel disease observed in mice deficient in various immune effectors (reviewed in the studies by Schreiber et al., 2005; Xavier and Podolsk, 2007; Van Limbergen et al., 2009; Kaser et al., 2010; Saleh and Trinchieri, 2011) . Much less explored is the importance of individual components of the intestinal epithelial barrier in preventing inflammatory bowel disease, and the potential contribution of intrinsic intestinal epithelial barrier defects to the development of the syndrome. The clearest indication of the potential importance of primary barrier integrity comes from studies of mice with germline ablation of Muc2 encoding the major mucin that shields the intestinal epithelium from direct contact with the microbiota. These mice develop colitis, which may progress to colon adenocarcinomas in older animals (Velcich et al., 2002) . Additional evidence has been obtained from transgenic mice with intestinal epithelial-specific overexpression of myosin light-chain kinase, which display decreased barrier function and increased immune activation, although an inflammatory bowel-like syndrome did not emerge in the absence of additional immunological challenges (Su et al., 2009) .
Matriptase is a member of the recently established family of type II transmembrane serine proteases that is encoded by the Suppression of Tumorigenicity-14 (ST14) gene (Kim et al., 1999; Lin et al., 1999; Takeuchi et al., 1999; Tanimoto et al., 2001; Bugge et al., 2009) . ST14 was originally proposed to be a colon cancer tumorsuppressor gene, due to its specific downregulation in adenocarcinomas of the colon (Zhang et al., 1998) . Matriptase is expressed in multiple epithelia of the integumental, gastrointestinal and urogenital systems, where it has pleiotropic functions in the differentiation or homeostasis of both simple and stratified epithelia, at least in part through the proteolytic activation of the epithelial sodium channel activator, prostasin/PRSS8 (Szabo and Bugge, 2011) . In the simple epithelium of the gastrointestinal tract, a principal function of matriptase is to promote the formation of a paracellular permeability barrier, possibly through the posttranslational regulation of the composition of claudins that are incorporated into the epithelial tight junction complex of differentiating intestinal epithelial cells (List et al., 2009; Buzza et al., 2010) .
Through lineage-specific loss-of-function analysis in mice, we now have examined the role of St14 as a tumor-suppressor gene. Interestingly, we found that the selective ablation of St14 from the intestinal epithelium results in the formation of adenocarcinoma of the colon with very early onset and high penetrance. Neoplastic progression occurs in the absence of exposure of animals to carcinogens or tumor-promoting agents, is preceded by chronic colonic inflammation that resembles human inflammatory bowel disease and can be suppressed by aggressive antibiotics treatment. This study demonstrates that inflammation-associated colon carcinogenesis can be initiated solely by intrinsic paracellular permeability barrier perturbations, and establishes that St14 is a critical tumor-suppressor gene in the mouse gastrointestinal tract.
Results
Meta-analysis of transcriptomes shows decreased expression of ST14 in human colon adenomas and adenocarcinomas We first performed in silico data mining of the Oncomine microarray database (Rhodes et al., 2004) to corroborate the initial report of reduced ST14 expression in human colon cancer (Zhang et al., 1998) (Figure 1 ). Interestingly, ST14 was significantly downregulated compared with the normal colon in 7 of the 14 published studies listed in the database (studies A and C-H), whereas 6 studies showed no change (studies B and J-N) and a single study (study I) found ST14 to be upregulated (Figure 1 and Supplementary Table 1) . Of the 14 studies, study A, which compared gene expression in colorectal dysplastic adenomatous polyps with the normal colonic epithelium, was conducted using laser capture microdissected tissue (ST14 downregulation, Po0.0006) (Gaspar et al., 2008) , and therefore provided the most reliable estimate of ST14 expression in normal and dysplastic colonic epithelium.
The St14-ablated colonic epithelium undergoes rapid and spontaneous malignant transformation To specifically explore the functional consequences of intestinal loss of St14 on colon carcinogenesis, we interbred mice carrying an St14
LoxP allele (List et al., 2009 ) with mice carrying an St14 null allele (St14 À ) and mice carrying a Cre transgene under the control of the intestinal-specific villin promoter (villin-Cre þ ) (Madison et al., 2002) . This resulted in the generation of villinCre
LoxP/À mice (hereafter termed 'St14 À ' mice) and their associated littermates villin-Cre
þ ' mice). As reported recently (List et al., 2009) , this strategy resulted in the efficient deletion of matriptase from the entire intestinal tract, as shown by the loss of matriptase immunoreactivity in the colon (compare Supplementary Figures 1a and b) and the small intestine (compare Supplementary Figures 1c and  d) , and by highly diminished St14 transcript abundance (Supplementary Figure 1e) . St14 À mice were outwardly unremarkable at birth, but displayed significant growth retardation after weaning (Supplementary Figure 1f) . Examination of prospective cohorts of St14 À mice and their associated littermate controls revealed that intestinal St14 ablation greatly diminished life span (Supplementary Figure 1g) .
Unexpectedly, histological analysis of moribund St14 À mice revealed the presence of invasive adenocar-*** 2 *** ** * *** *** * ** fold change Figure 2d ). Remarkably, in light of the fact that these mice were not carcinogen treated or exposed to other insults to the intestinal tract, adenocarcinoma could be found in mice o5 weeks of age (Table 1 ). All adenocarcinomas had progressed to invade the muscularis mucosae underlying the colonic epithelium and the subadjacent muscularis externa (Figures 2a and b) . Furthermore, in six of eight (75%) adenocarcinomas examined, tumor cells had infiltrated the lymphatic vasculature, as revealed by combined immunohistochemical staining with pan-keratin antibodies and antibodies against the lymphatic endothelial marker, LYVE-1 (Table 1 and . Importantly, the small intestine was histologically unremarkable in all mice examined (data not shown), although St14 was efficiently ablated also from this tissue (Supplementary Figures 1d and e) . Taken together, these data show that St14 is a critical tissue-specific tumorsuppressor gene in the mouse intestine that suppresses the formation of early, invasive adenocarcinomas of the colon.
Impaired barrier function in St14-ablated colon
We have previously shown that either reduced matriptase expression or global postnatal ablation of matriptase from all tissues results in impaired intestinal barrier function (List et al., 2009; Buzza et al., 2010) , suggesting that this would also be a feature of mice with intestinal epithelialspecific embryonic deletion of matriptase. To examine colonic and small intestinal barrier function, we injected a reactive biotin tracer into the intestinal lumen of 3-weekold St14 À and littermate St14 þ mice and followed the fate of the marker using fluorescent streptavidin. Compatible with an intact intestinal barrier function, the biotin marker decorated the surface of colonic crypts and villi of the small intestine, but did not penetrate into the tissue of St14 þ mice (Figures 5a and d) . In contrast, just 3 min after intraluminal biotin injection, the biotin tracer could be found on the basolateral membranes and on connective tissue cells of the colon and small intestine of St14 À mice demonstrating a profound failure to establish a functional intestinal barrier (Figures 5b and e) .
Neoplastic progression occurs within a chronic inflammatory colonic microenvironment that resembles inflammatory bowel disease The St14-ablated colonic tissue was histologically unremarkable when examined at birth and at postnatal day 5 (compare Figures 6a, a 0 , b and b 0 ). The first observable pathological manifestation (day 10) was the detachment and apoptosis (anoikis) of distal crypt cells (compare Figures 6c and c 0 ). This was followed by the failure of colonic epithelial cells to undergo proper terminal differentiation, as evidenced by cessation of mucin formation (data not shown). Thereafter, St14 À colons entered a progressively hyperplastic inflammatory . BrdU (5-bromo-2 0 -deoxyuridine)-incorporating cells initially were confined to the bottom of the crypts, but later were also present also in distal segments of the crypts (data not shown). Inflammatory infiltrates were evident at day 15. Inflammation at first was mild, but rapidly became severe, with inflammatory cells eventually constituting the dominant cell population of the mucosa and submucosa. Polyps were not observed in any of the examined colons before malignant transformation, indicating that St14 ablation-associated adenocarcinomas, like inflammatory bowel disease-associated colorectal cancers, arise from flat lesions within hyperproliferative and inflamed mucosa.
Abnormal epithelial differentiation and activation of inflammatory pathways precede inflammatory bowel disease-like colitis and dysregulation of common colon cancer-associated signaling pathways To elucidate the molecular events that precede the early development of colitis in mice with matriptase-ablated Table 1 for additional details.
Epithelial barrier defect-induced carcinogenesis P Kosa et al colonic epithelium, we next performed stage-specific transcriptomic analysis using whole-genome arrays. We selected two time points (days 0 and 5) where the matriptase-ablated colonic epithelium was histologically normal, and one time point (day 10) where pathological changes were emerging (see above). The analysis was Epithelial barrier defect-induced carcinogenesis P Kosa et al repeated four times for each of the three time points by analyzing individual St14 À mice and their associated St14 þ littermates. Genes that were more than twofold upregulated or downregulated in each of the four separate experiments were considered for analysis. No significant differences in the transcriptomes of St14-ablated and St14-sufficient colons were apparent at day 0 (data not shown). Interestingly, however, dysregulation of epithelial differentiation was apparent already at day 5 and was pronounced at day 10 (Tables 2 and 3 ). This was evidenced by the conspicuous upregulation of genes typically expressed in the basal, suprabasal or keratinizing layers of the stratified squamous epithelium lining the oral cavity, interfollicular epidermis, hair and nails of follicular epidermis, as well as filiform papillae of the tongue. These included keratin 14 (Krt14), keratin 36 (Krt36), keratin 84 (Krt84), small protein-rich protein 1a (Sprr1a), small protein-rich protein 2h (Sprr2h) and secreted Ly6/Plaur domain containing 1 (Slurp1). Abnormal colonic epithelial differentiation at day 5 was further evidenced by the downregulation of the expression of Paneth cell-specific alpha-defensin 4 (Defa4). Although St14 À colonic tissues were histologically normal at day 5, activation of inflammatory pathways was evidenced by the increased expression of several inflammation-associated genes, including chemokine (C-X-C motif) ligand-1 (Cxcl1), matrix metalloproteinase 10 (Mmp10), lymphocyte antigen 6 complex, locus C2 (Ly6c2), tumor necrosis factor (Tnf), myelin and lymphocyte protein (Mal), serum amyloid Epithelial barrier defect-induced carcinogenesis P Kosa et al A3 (Saa3), lymphocyte antigen 6 complex, locus I (Ly6i), lymphocyte antigen 6 complex, locus D (Ly6d) and GPI-anchored molecule-like protein (Gml). Inflammatory circuit activation was manifest at day 10, with upregulated expression of a number of additional inflammation-associated genes, including receptor-interacting serine-threonine kinase 3 (Ripk3), lipopolysaccharide-binding protein (Lbp), lactotransferrin (Ltf), TNFAIP3-interacting protein 3 (Tnip3), secretory leukocyte peptidase inhibitor (Slpi), leucine-rich alpha-2-glycoprotein 1 (Lrg1) and chemokine (C-X-C motif) ligand 5 (Cxcl5). Several epithelial proliferation-associated genes also were upregulated at day 10, including genes encoding the growth factors amphiregulin (Areg), heparin-binding EGF-like growth factor (Hbegf) and the p53-binding proliferation inducer, tripartite motif containing-29 (Trim29). Taken together, the combined stage-specific histological and transcriptomic analyses show that colonic epithelial ablation of matriptase causes aberrant early postnatal epithelial differentiation that triggers expression of pro-inflammatory mediators, which in turn causes persistent inflammation and chronic epithelial hyperproliferation. Colonic tumor initiation in humans and animal models is frequently linked to dysregulated bone morphogenetic protein (BMP), Notch and Wnt signaling, leading to the expansion of the colonic stem cell population (de Lau et al., 2007; Hardwick et al., 2008; Medema and Vermeulen, 2011; Zeki et al., 2011) . Therefore, we examined the level of expression of several putative and validated colonic stem cell markers (Aldh1a1, Ascl2, Ets2, Lgr5, Phlda1), as well as BMP (Cbfb, Dlx2, Hes1, Id1, Id2, Id3, Id4, Junb, Sox4, Stat1), Notch (Cdkn1a, Ccdn1, Cdk2, Hes1, Hes6, Klf4, Myc, Nfkb2) and Wnt (Ascl2, Axin2, Cd44, Csnk1a1, Csnk1d, Csnk1e, Ctnnb1, Cryl1, Ephb2, Ephb3, Gfi1, Hdac2, Id3, Ihh, Lef1, Myc, Nkd1, Nlk, Pascin2, Pcna, Plat, Rbbp4, Snai1, Sox4, Sox9, Spdef, Stra6, Tcf4, Yes1) target genes in St14 Table 2 ). This transcriptomic analysis provided no clear evidence of stem cell expansion or dysregulation of either of the three signaling pathways at day 0, at day 5, when abnormal differentiation and innate immune activation were apparent or even at day 10, when abnormal colonic morphology was manifest. In agreement with this analysis, expression of the Wnt target, Sox9, in St14 À mice was appropriately confined to the crypts at day 10, and aberrant localization of Sox9 was not detected until day 15 (Supplementary Figure 2) .
Diminution of the intestinal microbiota retards development of inflammatory bowel disease-like colitis
We hypothesized that the chronic inflammatory microenvironment that facilitated neoplastic progression of the St14-ablated colonic epithelium was generated in part by increased exposure of the mucosal immune system to the resident microbiota due to impaired barrier formation and aberrant differentiation. To challenge this hypothesis, we next treated weaning-age Epithelial barrier defect-induced carcinogenesis P Kosa et al
St14
À mice with a cocktail of the four antibiotics, ampicillin, neomycin, metronidazole and vancomycin or with vehicle for 2 weeks, a standard procedure for cleansing of the intestinal microbiota (Rakoff-Nahoum et al., 2004) . Owing to the failure of some of the four antibiotics to be present in milk, the treatment was initiated at weaning, when significant pre-neoplastic progression was already apparent (Figures 6e and e 0 ). As expected, antibiotics treatment reduced the colonic bacterial load by B1500-fold, as judged by the abundance of bacterial 16S ribosomal DNA in feces (Figure 7a ), without compromising body weight (Figure 7b ). Helicobacter is commonly found in the commensal microbiota of mice and promotes neoplastic progression in various models of colon carcinogenesis (Newman et al., 2001; Engle et al., 2002; Erdman et al., 2003; Maggio-Price et al., 2006; Hale et al., 2007) . Therefore, we specifically determined the presence of helicobacter DNA in feces of antibiotics-treated and antibiotics-untreated St14 À mice by PCR analysis (Supplementary Table 3 ). In all, 9 of 17 (53%), 7 of 17 (41%) and 1 of 17 (6%) control mice tested were positive for Helicobacter typhlonius, Helicobacter rodentium and for an undetermined Helicobacter species, respectively, whereas 2 of 13 (15%) of the analyzed antibiotics-treated mice were positive for H. typhlonius. Although initiated only after weaning, antibiotics treatment markedly blunted abnormal epithelial differ- Figure 3a , compare lanes 7-10 with 13 and 14), and Sox9 was only infrequently found in the distal portion of the colonic crypts of antibiotics-treated
À mice (Supplementary Figures 2d and e) , suggesting a diminution of Wnt signaling. Analysis of BMP (phospho-SMAD1/5) and Notch1 (Notch1 intracellular domain) signaling did not reveal a treatment-or genotype-specific pattern, but the abundance of each of the two protein species in intestinal tissue extracts was difficult to assess accurately (Supplementary Figure 3b) .
Taken together, the data are compatible with a principal role of the commensal microbiota in preneoplastic progression. A mechanistic model for matriptase ablation-induced colon cancer based on the above findings is shown in Figure 9 . We propose that the intrinsic defect in barrier function associated with Epithelial barrier defect-induced carcinogenesis P Kosa et al the failure to form functional tight junctions (List et al., 2009; Buzza et al., 2010) causes increased exposure of the immune system to the commensal microbiota.
This exposure elicits vigorous inflammatory and repair responses that involve epithelial stem cell activation and are continuous, rather than transient, due Epithelial barrier defect-induced carcinogenesis P Kosa et al to the inherent failure of matriptase-ablated colonic epithelial cells to establish a functional barrier. The sustained hyperproliferation of epithelial stem cells within a genotoxic chronic inflammatory microenvironment in turn induces progressive genomic instability and subsequent rapid malignant conversion.
Discussion
It has long been suspected that intrinsic alterations in the paracellular intestinal permeability barrier in humans could be a priming factor for development of the aberrant immune response to the commensal microbiota Epithelial barrier defect-induced carcinogenesis P Kosa et al
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Epithelial barrier defect-induced carcinogenesis P Kosa et al that underlies inflammatory bowel disease and its associated malignancies. This study now provides strong experimental support for this notion by showing that intestinal epithelial-specific ablation of matriptase-a membrane-anchored serine protease that is essential for intestinal epithelial tight junction formation-causes a commensal microbiota-dependent inflammatory bowel disease-like colitis that very rapidly progresses to adenocarcinoma. Furthermore, the spontaneous and rapid malignant transformation of the colonic epithelium demonstrates that a simple increase in intestinal paracellular permeability suffices to both initiate and drive inflammation-associated adenocarcinoma formation. This finding parallels the recent identification of the permeability of the epidermal barrier as a major determinant of the development of other chronic inflammatory diseases, including ichthyosis vulgaris, atopic eczema and asthma (Smith et al., 2006; Sandilands et al., 2009) . Previously published animal models of inflammatory bowel disease-associated colorectal cancer include dextran sodium sulfate-induced or dextran sodium sulfate combined with azoxymethaneinduced chemical colon carcinogenesis in inbred mouse strains (Okayasu et al., 1996 (Okayasu et al., , 2002 , and genetic models, including germline Il10-ablated (Berg et al., 1996) , combined germline Tbx21-and Rag2-ablated (Garrett et al., 2009) , myeloid lineage Stat3-ablated (Deng et al., 2010) , myeloid lineage Itgav-ablated (Lacy-Hulbert et al., 2007), germline Gnai2-ablated (Rudolph et al., 1995) and combined germline Il2-and b2m-ablated mice (Shah et al., 1998) . In these models, colitis and colon carcinoma occur as a consequence of either a sustained chemical damage to the colonic epithelium or perturbation of the immune system through elimination of key effectors of innate or adaptive immunity. Compared with the above models, colon carcinogenesis in intestinal St14-ablated mice appears to display some unique features. First, it is initiated by a loss of intestinal barrier function, which is associated with aberrant differentiation and immune activation, but these priming events initially occur in the absence of detectable perturbation of common colon cancer-associated signaling pathways (Kaiser et al., 2007) . Second, adenocarcinoma with involvement of lymphoid tissues is observed even in very young animals. This very rapid neoplastic progression may be explained, at least in part, by the presence of various Helicobacter species in the intestinal microbiota of St14 À mice, as colon carcinogenesis in several mouse models has been shown to be accelerated by or to be dependent upon Helicobacter colonization (Newman et al., 2001; Engle et al., 2002; Erdman et al., 2003; Maggio-Price et al., 2006; Hale et al., 2007) .
In light of the findings in this study, it is tempting to speculate that neoplastic progression in previously described mouse models of inflammatory bowel disease-associated colorectal cancer (and perhaps colitisassociated human colorectal cancer) may be accelerated by an immune activation-induced decrease in the intestinal paracellular permeability barrier caused by downregulating the activity of matriptase or other molecules within a matriptase-dependent proteolytic pathway that facilitates tight junction formation.
Conclusive links have been forged between increased activity of multiple members of the complement of extracellular and pericellular proteases and the initiation and progression of a vide variety of human malignancies (reviewed in the studies by Andreasen et al., 2000; NetzelArnett et al., 2003; Borgono and Diamandis, 2004; Mohamed and Sloane, 2006; Kessenbrock et al., 2010) . Much less studied is the capacity of extracellular/ pericellular proteases to act as suppressors of tumorigen- Immunohistochemical staining for B-cells (panels e and f), T-cells (panels g and h) and neutrophils (panels i and j) in untreated (panels e, g and i) and antibiotics-treated (panels f, h and j) St14
À colons shows reduced chronic (examples with arrowheads in panels e-h) and acute (examples with arrowheads in panels i and j) inflammatory cell infiltration. Scale bar ¼ 50 mm.
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Regenerative atypia Figure 9 Model for matriptase ablation-induced colon carcinogenesis. Loss of matriptase from the intestinal epithelium compromises epithelial barrier function, thereby causing exposure of the commensal microbiota to resident immune cells. This triggers a repair response that includes activation of local inflammatory circuits and colonic stem cell activation. This response is perpetual, rather than transient, due to the intrinsic inability of matriptase-ablated intestinal epithelium to form a functional barrier. Persistent hyperproliferation of colonic stem cells within a DNA-damaging chronic inflammatory microenvironment causes the formation of adenocarcinoma.
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Epithelial barrier defect-induced carcinogenesis P Kosa et al esis (reviewed in the studies by Lopez-Otin and Matrisian, 2007; Lopez-Otin et al., 2009) . Induced germline or lineage-specific gene deletion studies in mice and spontaneous somatic mutation analysis of human cancers have provided direct evidence for a tumor-suppressive function of matrix metalloproteinase 3 (MMP3) (McCawley et al., 2004 (McCawley et al., , 2008 , MMP8 (Balbin et al., 2003; Palavalli et al., 2009) , MMP12 (Acuff et al., 2006) and Cathepsin L (Reinheckel et al., 2005) . Furthermore, the frequent epigenetic and genetic silencing of other extracellular and pericellular proteases in human cancers and the ability to inhibit distinct steps of tumor progression in experimental models of cancer through modulation of their level of expression suggest that the number of extracellular and pericellular proteases with tumor-suppressive function may be substantial (reviewed in the studies by Lopez-Otin and Matrisian (2007) and Lopez-Otin et al. (2009) ). This study adds matriptase to the above list of pericellular proteases with tumor-suppressive functions. Matriptase, however, so far is unique among pericellular proteases in the sense that its absence by itself suffices to cause malignancy, whereas the tumor-suppressive function of other proteases was revealed in chemical and transplantation models of cancer.
Previous studies have shown that overexpression of matriptase can initiate carcinogenesis and accelerate dissemination of various carcinomas in diverse model systems. This property of matriptase is owed at least in part to its ability to autoactivate (Oberst et al., 2003) and subsequently serve as an initiator of several intracellular signaling and proteolytic cascades through proteolytic maturation of growth factors, proteaseactivated receptor activation and protease zymogen conversion (Lee et al., 2000; Takeuchi et al., 2000; Ihara et al., 2002; Suzuki et al., 2004; Forbs et al., 2005; List et al., 2005; Jin et al., 2006; Kilpatrick et al., 2006; Netzel-Arnett et al., 2006; Bhatt et al., 2007; Cheng et al., 2009; Owen et al., 2010; Sales et al., 2010; Ustach et al., 2010; . The dual ability of a protease to promote carcinogenesis in some contexts, while suppressing carcinogenesis in others, is rare, but not entirely unprecedented. A clear example is given by the tumor-promoting effect of transgenic misexpression of the stromal protease, MMP3, in the mammary epithelial compartment, as opposed to the strong protection of mice from chemically induced squamous cell carcinogenesis caused by germline ablation of the protease (Sternlicht et al., 1999 (Sternlicht et al., , 2000 McCawley et al., 2004 McCawley et al., , 2008 . Additional proteases, such as MMP9, MMP11 and MMP19 may also promote or suppress, respectively, malignant progression in a stage or tissuedependent manner (Lopez-Otin and Matrisian, 2007) .
In conclusion, our study has uncovered a critical role of the transmembrane serine protease matriptase in preserving immune homeostasis in the gastrointestinal tract and in suppressing the formation of colitis and colitis-associated adenocarcinoma formation. Furthermore, this study surprisingly reveals that the simple perturbation of the epithelial permeability barrier suffices to rapidly and efficiently induce malignant transformation of the colonic epithelium.
Materials and methods
Animal experiments
All procedures involving live animals were performed in an Association for Assessment and Accreditation of Laboratory Animals Care International-accredited vivarium following institutional guidelines and standard operating procedures. Within the study period, sentinels within the mouse holding room sporadically tested positive for Helicobacter, murine norovirus and mouse parvovirus, and tested negative for ectromelia virus, mouse rotavirus, Theiler's encephalomyelitis virus (GDVII strain), lymphocytic choriomeningitis virus, mycobacteria, mouse hepatitis virus, minute virus of mice, mouse polyoma virus, pneumonia virus of mice, reovirus type 3, Sendai virus and fecal endoparasites and ectoparasites. The NIDCR Institutional Animal Care and Use Committee approved this study. All studies were strictly littermate controlled. St14 knock out (St14 À/À ) and conditional knockout (St14 LoxP/LoxP ) mice have been described previously (List et al., 2002 (List et al., , 2009 ). Villin-Cre þ /0 (B6.SJL-Tg(Vil-Cre)997Gum/J) mice (Madison et al., 2002) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). All experimental animals were in a mixed 129/C57BL6/J/NIH Black Swiss/ FVB/NJ background. The genotypes of all mice were determined by PCR of ear or tail biopsy DNA. St14 þ and St14
LoxP alleles were detected using the primers 5 0 -CAGTGC TGTTCAGCTTCCTCTT-3 0 and 5 0 -GTGGAGGTGGAGTT CTCATACG-5 0 , respectively. The presence of the St14 knock out allele was detected using primers 5 0 -GTGGAGGTGG AGTTCTCATACG-3 0 and 5 0 -GTGCGAGGCCAGAGGCC ACTTGTGTAGCG-3 0 . The Cre transgene was detected using the primers 5 0 -GCATAACCAGTGAAACAGCATTGCT G-3 0 and 5 0 -GGACATGTTCAGGGATCGCCAGGCG-3 0 . For antibiotics treatment, mice were administered a combination of ampicillin (1 g/l, Sigma-Aldrich, St Louis, MO, USA), neomycin (1 g/l, Sigma-Aldrich), metronidazole (1 g/l, Sigma-Aldrich) and vancomycin (0.5 g/l, Sigma-Aldrich) in drinking water for 2 weeks, starting immediately after weaning (P20).
Quantitative PCR analysis RNA was prepared from mouse organs by extraction in TRIzol reagent (Invitrogen, Carlsbad, CA, USA), as recommended by the manufacturer. First-strand cDNA synthesis was performed using oligo (dT) primers with the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA). An iCycler, gene expression analysis software and IQ SYBR Green Supermix (all from Bio-Rad Laboratories) were used for quantitative PCR analysis in accordance with the manufacturer's instructions, using a primer complementary to sequence of matriptase exon 1, 5 0 -AACCATGGGTAGCA ATCGGGGC-3 0 , and matriptase exon 2, 5 0 -AACTCCACAC CCTCCTCAAAGC-3 0 (annealing temperature 60 1C, denaturation temperature 95 1C, 40 cycles). Matriptase expression levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh) levels in each sample. Gapdh mRNA was amplified with the primers 5 0 -GTGAAGCAGGCATCTGAG G-3 0 and 5 0 -CATCGAAGGTGGAAGAGTGG-3 0 (annealing temperature 60 1C, denaturation temperature 95 1C, 40 cycles). (Riley et al., 1996; Feng et al., 2005) .
Quantification of bacterial intestinal colonization
Intestinal tight junction assay
In all, 50 ml of 10 mg/ml EZ-Link Sulfo-NHSLC-Biotin (Thermo Fisher Scientific, Waltham, MA, USA) in phosphate-buffered saline containing 1 mmol/l CaCl 2 was injected into the lumen of the distal colon and jejunum of 3-week-old St14 À and St14 þ littermates that were anesthetized by intraperitoneal injection of an anesthetic combination (ketamine (20 mg/ml), xylazine (2 mg/ml), 50 ml/10 g). After 3 min incubation, mice were killed, and the injected portion of the intestine was excised and fixed in 10% neutral-buffered zinc formalin (Z-fix, Anatech, Battle Creek, MI, USA) for 3 h, processed into paraffin and sectioned. Five 1-mm sections were blocked for 30 min in blocking solution (5% bovine serum albumin in phosphate-buffered saline), and then incubated for 1 h at room temperature with streptavidin Alexa Fluor 448 conjugate (Invitrogen) (5 mg/ml) in blocking solution. Sections were washed three times with phosphate-buffered saline and mounted with VECTASHIELD HardSet Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA, USA). Images were acquired on an Axio Imager. Z1 microscope using an AxioCam HRc/MRm digital camera (Carl Zeiss Ltd, Jena, Germany).
Histopathology
Mice were killed by CO 2 inhalation. Tissues were fixed for 24 h in Z-fix, processed into paraffin, cut into 5 mm sections and stained with hematoxylin and eosin. For visualization of mucin production, sections were stained using the Periodic acidSchiff kit (Sigma-Aldrich) or Alcian Blue (1% Alcian Blue in 3% acetic acid). Collagen was detected using Massontrichrome staining.
Immunohistochemistry
Tissue sections were prepared and antigens retrieved by heating in epitope-retrieval buffer (0.01 M sodium citrate, pH 6.5) or Epitope Retrieval Buffer-Reduced pH (Bethyl Laboratories, Montgomery, TX, USA) for matriptase immunohistochemistry (IHC). Sections were blocked for 1 h in 5% bovine serum albumin (Sigma-Aldrich) or 10% horse serum (for matriptase IHC) in phosphate-buffered saline and incubated overnight at 41C with primary antibody: matriptase (Sheep, Polyclonal, R&D Systems, Minneapolis, MN, USA), cytokeratins (Rabbit, Polyclonal, DakoCytomation, Carpinteria, CA, USA), LYVE-1 (Goat, Polyclonal, R&D Systems), b-catenin (Rabbit, Monoclonal, Cell Signaling, Danvers, MA, USA), laminin (Rabbit, Polyclonal, Sigma-Aldrich), BrdU (Rat, Monoclonal, Accurate Chemicals and Scientific, Westbury, NY, USA), CD3 (Rabbit, Polyclonal, DakoCytomation), klight chain (Rabbit, Polyclonal, DakoCytomation), Ki67 (Rabbit, Polyclonal, Novocastra, Westbury, NY, USA), myeloperoxidase (Rabbit, Polyclonal, DakoCytomation) and Sox9 (Rabbit, Polyclonal, Millipore, Temecula, CA, USA). Bound antibodies were visualized using either biotin-conjugated horse anti-goat, goat anti-rabbit, goat anti-rat (Vector Laboratories), rabbit anti-sheep (Thermo Scientific, Rockford, IL, USA) or alkaline phosphatase-conjugated donkey antirabbit (DakoCytomation) secondary antibodies and a Vectastain ABC kit (Vector Laboratories) using 3,3 0 -diaminobenzidine substrate (Sigma-Aldrich) or Vulcan Fast Red Chromogen Kit 2 (Biocare Medical, Concord, CA, USA). Hematoxylin was the counterstain.
Immunoblotting Approximately 1 cm of the distal part of large intestine was homogenized and lysed in 25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS and protease inhibitor cocktail (Sigma-Aldrich). Boiled and reduced samples were subjected to immunoblotting using primary antibodies: anti-b-catenin (Rabbit, Monoclonal, Cell Signaling), anti-phospho-SMAD1/5 (Rabbit, monoclonal, Cell Signaling), anti-Notch1 (Rabbit, monoclonal, Cell Signaling) and anti-GAPDH (Rabbit, polyclonal, Santa Cruz Biotechnology, Santa Cruz, CA, USA). The signal was detected with secondary anti-rabbit antibody conjugated to either alkaline phosphatase (DakoCytomation) or horseradish peroxidase (Thermo Scientific).
Microarray analysis
Microarray analysis of gene expression was performed using Mouse GE 4 Â 44 K v2 Microarray slides (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's instructions. In brief, the colon tissue was dissected from four pairs of St14 À and littermate St14 þ mice. RNA was isolated using TRIzol reagent, as recommended by the manufacturer. The quality and the integrity of the RNA were determined using the 2100 Bioanalyzer platform (Agilent Technologies). Isolated colon RNA together with Universal Mouse Reference RNA (Agilent Technologies) were labeled using the Two-color Quick Amp Labeling Kit (Agilent Technologies). Labeled RNA was hybridized to the slides overnight. After washing, the slides were scanned using a high-resolution microarray scanner. The raw microarray image files were read and processed using the Feature Extraction Software (Agilent Technologies). The analysis of microarray data was performed using Gene Spring Software (Agilent Technologies). Gene expression was normalized to the universal reference RNA. From the original data set, only probes flagged as detected at least in one sample were selected. These data sets were further filtered for probes with two or more fold change in expression between St14 þ and St14 À tissues. Statistical analysis of these data sets led to the identification of probes with significantly different change in gene expression using unpaired Student's ttest with Benjamini-Hochberg multiple testing correction. Probes with Po0.05 were considered significant and are shown in Tables 2 and 3 .
Histomorphometric analysis Five control St14
À and six antibiotics-treated St14 À mice were analyzed. To determine mucosal thickness, 2 mm of the distal colon mucosa adjacent to the squamous epithelium of the rectum was identified on a hematoxylin and eosin section and the area was calculated using Aperio ImageScope software (Aperio, Vista, CA, USA). For quantification of proliferation, differentiation and inflammatory infiltrates, seven individual areas of distal colon on each slide were selected for counting. The number of counts was normalized to the surface of the selected area and averaged for each individual animal.
